UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000891
Receipt number R000001074
Scientific Title Prospective study of tansarterial embolization for hepatocellular carcinoma with Lipiodol added Lecithin.
Date of disclosure of the study information 2007/11/15
Last modified on 2007/11/14 20:02:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study of tansarterial embolization for hepatocellular carcinoma with Lipiodol added Lecithin.

Acronym

Tansarterial embolization for hepatocellular carcinoma with Lipiodol added Lecithin.

Scientific Title

Prospective study of tansarterial embolization for hepatocellular carcinoma with Lipiodol added Lecithin.

Scientific Title:Acronym

Tansarterial embolization for hepatocellular carcinoma with Lipiodol added Lecithin.

Region

Japan


Condition

Condition

hepatocellar carcinoma

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Our objectives are improvement in the treatment of the primary hepatocellular carcinoma and improvement of convalescence of transcatheter arterial embolization, in useing the emulsion which added the lecithin (surfactant in Lipiodol).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

curative effect,response rate,survival time, survival rate

Key secondary outcomes

adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Lecithin Group:We use the emulsion which added the lecithin which is a surfactant in Lipiodol for transcatheter arterial embolization.

Interventions/Control_2

Non-Lecithin Group:We use the Lipiodol which didn't add the lecithin for transcatheter arterial embolization.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1:Histologically proven or clinically diagnosed hepatocellular carcinoma in primary lesion.
2:Age20-85
3:Performance Status0-1(ECOG)
4:Life expectancy at least 3 months.
5:Adequate organ and marrow function listed below.
a.White blood cell(WBC):3,000<=WBC<12,000/uL
b.Absolute neutrophil count(Neu):Neu >=1,800/uL
c.Hemoglobin(Hb): Hb>=8.0g/dL
d.Serum creatinine(Cr):W.N.L
e. Electrocardiogram(ECG):normal
6:Do not become the adaptation of resection,transplant,and local treatment in algorithm of HCC treatment.
7:Without contraindication of TAE.
8:The patient who have given written informed consent to participant in this study.

Key exclusion criteria

1:The patient with the anamnesis of the drug hypersensitivity.
2:The patient with contraindication of medication(Hydrochloric acid doxorubicin, Lipiodol, Gelpert and lecithin).
3:The patient with contraindication of TAE.
a.Severe liver failure
b.Serum Bilirubin(T-Bil):T-Bil>3mg/dl
c.Large quantities of acites.
4:The patient having the activity-related infectious disease(more than fever 38.0 degrees ).
5:The patient having the a serious complication.
6:Pregnant woman.
7: Patients who are judged inappropriate to be enrolled in this study by the doctor in charge.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masakazu Yamamoto

Organization

Tokyo Women's Medical University

Division name

Department of Surgery, Institute of Gastroenterology

Zip code


Address

8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-8111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shun-ichi Ariizumi, Yutaka Takahashi ,

Organization

Tokyo Women's Medical University

Division name

Department of Surgery, Institute of Gastroenterology

Zip code


Address

8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-8111

Homepage URL


Email

yutaka@ige.twmu.ac.jp


Sponsor or person

Institute

Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Women's Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

none


Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2007 Year 03 Month 17 Day

Date of IRB


Anticipated trial start date

2007 Year 04 Month 01 Day

Last follow-up date

2009 Year 12 Month 01 Day

Date of closure to data entry

2009 Year 12 Month 01 Day

Date trial data considered complete

2009 Year 12 Month 01 Day

Date analysis concluded

2009 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 11 Month 14 Day

Last modified on

2007 Year 11 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001074


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name